Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Barbarea verna ATP synthase subunit a, chloroplastic (atpI), partial CSB-YP393342BOQ1
CSB-EP393342BOQ1
CSB-BP393342BOQ1
CSB-MP393342BOQ1
CSB-EP393342BOQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna DNA-directed RNA polymerase subunit beta' (rpoC1), partial CSB-YP393343BOQ
CSB-EP393343BOQ
CSB-BP393343BOQ
CSB-MP393343BOQ
CSB-EP393343BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna Cytochrome b6-f complex subunit 8 (petN), partial CSB-YP393344BOQ
CSB-EP393344BOQ
CSB-BP393344BOQ
CSB-MP393344BOQ
CSB-EP393344BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna 30S ribosomal protein S4, chloroplastic (rps4) CSB-YP393345BOQ
CSB-EP393345BOQ
CSB-BP393345BOQ
CSB-MP393345BOQ
CSB-EP393345BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna ATP synthase subunit beta, chloroplastic (atpB) CSB-YP393346BOQ
CSB-EP393346BOQ
CSB-BP393346BOQ
CSB-MP393346BOQ
CSB-EP393346BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna Photosystem I assembly protein Ycf4 (ycf4), partial CSB-YP393347BOQ1
CSB-EP393347BOQ1
CSB-BP393347BOQ1
CSB-MP393347BOQ1
CSB-EP393347BOQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna Cytochrome b6-f complex subunit 5 (petG), partial CSB-YP393348BOQ
CSB-EP393348BOQ
CSB-BP393348BOQ
CSB-MP393348BOQ
CSB-EP393348BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP393349BOQ
CSB-EP393349BOQ
CSB-BP393349BOQ
CSB-MP393349BOQ
CSB-EP393349BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna 30S ribosomal protein S8, chloroplastic (rps8) CSB-YP393350BOQ
CSB-EP393350BOQ
CSB-BP393350BOQ
CSB-MP393350BOQ
CSB-EP393350BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna 30S ribosomal protein S3, chloroplastic (rps3) CSB-YP393351BOQ
CSB-EP393351BOQ
CSB-BP393351BOQ
CSB-MP393351BOQ
CSB-EP393351BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna Putative uncharacterized protein ycf15 (ycf15-A) CSB-YP393352BOQ
CSB-EP393352BOQ
CSB-BP393352BOQ
CSB-MP393352BOQ
CSB-EP393352BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna NAD (P)H-quinone oxidoreductase subunit 5, chloroplastic, partial CSB-YP393353BOQ
CSB-EP393353BOQ
CSB-BP393353BOQ
CSB-MP393353BOQ
CSB-EP393353BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna NAD (P)H-quinone oxidoreductase subunit I, chloroplastic CSB-YP393354BOQ
CSB-EP393354BOQ
CSB-BP393354BOQ
CSB-MP393354BOQ
CSB-EP393354BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barbarea verna Putative membrane protein ycf1 (ycf1-A), partial CSB-YP393355BOQ
CSB-EP393355BOQ
CSB-BP393355BOQ
CSB-MP393355BOQ
CSB-EP393355BOQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Capsella bursa-pastoris Maturase K (matK), partial CSB-YP393356CWI
CSB-EP393356CWI
CSB-BP393356CWI
CSB-MP393356CWI
CSB-EP393356CWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Capsella bursa-pastoris DNA-directed RNA polymerase subunit beta' (rpoC2), partial CSB-YP393357CWI
CSB-EP393357CWI
CSB-BP393357CWI
CSB-MP393357CWI
CSB-EP393357CWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Capsella bursa-pastoris DNA-directed RNA polymerase subunit beta' (rpoC1), partial CSB-YP393358CWI
CSB-EP393358CWI
CSB-BP393358CWI
CSB-MP393358CWI
CSB-EP393358CWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Capsella bursa-pastoris Photosystem II CP43 chlorophyll apoprotein (psbC), partial CSB-YP393359CWI1
CSB-EP393359CWI1
CSB-BP393359CWI1
CSB-MP393359CWI1
CSB-EP393359CWI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Capsella bursa-pastoris 30S ribosomal protein S4, chloroplastic (rps4) CSB-YP393360CWI
CSB-EP393360CWI
CSB-BP393360CWI
CSB-MP393360CWI
CSB-EP393360CWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Capsella bursa-pastoris NAD (P)H-quinone oxidoreductase subunit K, chloroplastic CSB-YP393361CWI
CSB-EP393361CWI
CSB-BP393361CWI
CSB-MP393361CWI
CSB-EP393361CWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>